| Literature DB >> 31908738 |
Reyhaneh Farrokhi Yekta1, Nasrin Amiri-Dashatan1,2, Mehdi Koushki3, Masoomeh Dadpay4, Fatemeh Goshadrou5.
Abstract
BACKGROUND: Gastric Ulcer (GU) is the most prevalent gastrointestinal disorder induced by various factors and Non-Steroid Anti-Inflammatory Drugs (NSAIDs) as one of the most common reasons. Due to the absence of appropriate molecular markers for GU, the aim of this study was to utilize a metabolomics approach in order to find potential metabolite markers for the disease.Entities:
Keywords: Gastric ulcer; Indomethacin; Metabolomics; Nuclear magnetic resonance
Year: 2019 PMID: 31908738 PMCID: PMC6925398
Source DB: PubMed Journal: Avicenna J Med Biotechnol ISSN: 2008-2835
Figure 1.The macroscopic appearance of the stomach from (A, B) normal control, (C) control receiving CMC and (D–F) indomethacin-induced gastric ulcer rats. Arrows show linear and focal hemorrhagic areas.
Figure 2.The gastric mucosa appearance in (A) normal and (B, C) indomethacin-induced lesions stained with H&E (100x magnified). Normal stomachs have intact epithelium with distinct chief and parietal cells where ulcer areas show epithelium damage and infiltration of lymphocytes and monocytes.
Figure 3.The plot of the OOB error for the random forest model.
The RF model predictive performance features
| 0 | 100% | 100% | 100% | 100% | |
| 28.60% | 66.70% | 75% | 71.42% | 66.70% |
Figure 4.ROC curves demonstrating predictive performance of the RF model for (A) training and (B) test sets.
Figure 5.The representative 400 MHz CPMG 1H-NMR spectrum of rat stomach tissue. Altered metabolites between normal and indo-methacin-induced gastric ulcer samples are demonstrated. Key: 1-pantothenate, 2-isoleucine, 3-spermidine, 4-methionine, 5-acetylcarnitine, 6-trimethylamine, 7-creatinine, 8-carnitine, 9-cisaconitate, 10-choline, 11-taurine, 12-betaine, 13-glucose, 14-N,NDimethylglycine, 15-acetylcholine, 16-tryptophan, 17-kynurenine.
The significantly altered metabolites between GU and normal control
| 3.195, 3.505, 4.055, 3.515 | C00114 | 0.0331 | 0.0172 | 3.28 ↓ | |
| 3.095, 3.105 | C00417 | 0.0263 | 2.32E-05 | 2.05 ↓ | |
| 3.285, 3.295, 3.465, 3.475 | C00078 | 0.0240 | 0.0066 | 3.79 ↓ | |
| 3.155, 3.145 | C00315 | 0.0194 | 0.0010 | 6.40 ↓ | |
| 3.255 | C00565 | 0.0190 | 0.0276 | 1.75 ↑ | |
| 2.915, 3.705 | C01026 | 0.0190 | 0.0150 | 2.50 ↓ | |
| 3.175, 3.605, 3.185, 3.595 | C02571 | 0.0138 | 0.0184 | 1.90 ↓ | |
| 4.045 | C00791 | 0.0138 | 0.0157 | 6.60 ↓ | |
| 3.425 | C00864 | 0.0135 | 0.0085 | 3.52 ↓ | |
| 3.265 | C00719 | 0.0125 | 0.0490 | 1.60 ↓ | |
| 3.405, 3.415, 3.395, 3.385 | C00245 | 0.0125 | 0.0010 | 7.90 ↓ | |
| 3.205, 3.215 | C00318 | 0.0123 | 0.0128 | 1.80 ↑ | |
| 3.655, 3.665 | C00407 | 0.0121 | 0.0061 | 5.05 ↓ | |
| 3.455, 3.235, 3.525, 3.725, 3.825 | C00031 | 0.0119 | 0.0010 | 3.88 ↓ | |
| 3.695 | C00328 | 0.0114 | 0.0113 | 5.50 ↓ | |
| 2.115, 3.855 | C00073 | 0.0110 | 0.0447 | 2.18 ↓ | |
| 3.205 | C01996 | 0.0057 | 0.0285 | 2.00 ↑ |
Figure 6.The metabolite sets enrichment analysis (MSEA) overview.
The significant biochemical pathways involved in the pathogenesis of gastric ulcer
| Betaine, Dimethylglycine, Choline, Methionine | 2.62E-4 | 0.0216 | |
| Betaine, Dimethylglycine, Choline, Methionine, Spermidine | 4.37E-4 | 0.0216 | |
| Carnitine, Acetylcarnitine | 0.0304 | 0.839 | |
| Methionine, Spermidine | 0.0339 | 0.839 |